SF is a 50-year-old woman, counseled about the therapeutic use of psilocybin by her neurologist, who has participated in ...

The AMULET trial is comparing the anti-alpha-syn antibody to placebo in 61 patients with MSA, a rapidly progressing and rare condition that causes damage to nerve cells in the brain, to see if it ...

This valuable study proposes a novel rapid-entry mechanism of S. aureus that involves the rapid release of calcium from lysosomes. The strength of the paper lies in a very interesting hypothesis; what ...

Cite this: TNF Signaling Inhibition in the CNS: Implications for Normal Brain Function and Neurodegenerative Disease - Medscape - Oct 17, 2008.

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism ...